| pubmed-article:9504870 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9504870 | lifeskim:mentions | umls-concept:C0205476 | lld:lifeskim |
| pubmed-article:9504870 | lifeskim:mentions | umls-concept:C0151744 | lld:lifeskim |
| pubmed-article:9504870 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9504870 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:9504870 | lifeskim:mentions | umls-concept:C0683468 | lld:lifeskim |
| pubmed-article:9504870 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9504870 | pubmed:dateCreated | 1998-4-2 | lld:pubmed |
| pubmed-article:9504870 | pubmed:abstractText | The purpose of this study was to evaluate the outcomes of medical management compared with invasive management for patients with mild or moderate ischemia (non-high-risk) on stress tomographic myocardial perfusion scintigraphy. Of the 1,352 non-high-risk patients, 116 (9%) subsequently were referred for coronary angiography within the first 30 days after the scan; 99 (85%) of this group also underwent early revascularization procedures. The remaining 1,236 patients (91%) with non-high-risk ischemia did not undergo early invasive management. Unadjusted actuarial 3-year rate of cardiac death or nonfatal infarction was significantly better estimated survival in the medically managed group (2%) compared with the invasively managed group (22%), p = 0.0001. Subsequent coronary revascularization procedures during 3-year follow-up were less frequent in the medically managed group (4%) than in the invasively managed group (42%), p = 0.0001. A multivariable analysis identified invasive management strategy (p = 0.0001) as the only correlate of cardiac events during follow-up. In summary, this study showed that patients with non-high-risk ischemia on stress perfusion imaging can be treated safely with a conservative medical management strategy. | lld:pubmed |
| pubmed-article:9504870 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9504870 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9504870 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9504870 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9504870 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9504870 | pubmed:issn | 1071-3581 | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:CaseJJ | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:BatemanT MTM | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:O'KeefeJ... | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:BarnhartCC | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:LigonR WRW | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:CullomJJ | lld:pubmed |
| pubmed-article:9504870 | pubmed:author | pubmed-author:SpertusJJ | lld:pubmed |
| pubmed-article:9504870 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9504870 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:9504870 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9504870 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9504870 | pubmed:pagination | 28-33 | lld:pubmed |
| pubmed-article:9504870 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:meshHeading | pubmed-meshheading:9504870-... | lld:pubmed |
| pubmed-article:9504870 | pubmed:articleTitle | Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease. | lld:pubmed |
| pubmed-article:9504870 | pubmed:affiliation | Cardiovascular Consultants, PC, Mid America Heart Institute, Kansas City, Missouri, USA. | lld:pubmed |
| pubmed-article:9504870 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9504870 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9504870 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9504870 | lld:pubmed |
